Astrapreparat bra vid by-pass

En klinisk studie från Uppsala Clinical Research Centre visar fördelar med Astras preparat jämfört med standardbehandlingen.

Svenska innovationer visas upp på Arab Health

The Innovation Pavilion by Sweden invigdes den 29 januari i närvaro av särskilt inbjudna gäster från regionen, representanter från Socialdepartementet, Sveriges...

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Opinion: Where do all the cool Swedish life science companies go?

It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful...

Brighter förlänger erbjudandet

Ger mer tid till Division By Zeros aktieägare att acceptera bolagets köperbjudande.

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Köper virtual reality-teknik

Brighter köper e-hälsoföretaget Division By Zero.

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to ...

Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

When carelessness, forgetfulness and coincidence become the researcher’s best friend

Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advanc...

Drug development creates new challenges for regulators

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Framtidens laboratorium i fokus på fackmässan Analytica

Messe München laddar för att återigen ta emot världens laboratoriebransch

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Norway finds its path in life science

The life science sector in Norway is on the rise.

The perfect formula for decision-making

No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.

Torgny Fornstedt: Analytisk kemi måste hitta tillbaka till sina rötter

Det behövs fler kunniga analytiska kemister både på universiteten och inom industrin, skriver Torgny Fornstedt i en krönika.

It´s time to establish relations

Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.

Big pharma flyttar till KI

Det globala life science-bolaget Bayer flyttar in på KI:s campus. Flytten symboliserar kraften i samverkan säger företagets vd.

De fick Arvid Carlsson Award

Sedan förra året delar Sahlgrenska Science Park ut ett pris i nobelpristagaren Arvid Carlssons namn. Årets vinnare får priset för att de utvecklat en teknik i a...

Orexo vinner långdragen patenttvist

Amerikanska domstolen för överklagande slår fast att bolagets långa patent för Zubsolv är giltigt. Tidigare beslut som förklarade patentet ogiltigt rivs alltså upp.

Peptider kan bli framtidens läkemedel

Tyska forskare rapporterar ett genombrott i arbetet med att göra små proteiner tillgängliga som läkemedel i pillerform.